GATA3 (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "GATA3" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

16nih.gov

4^th place

8^th place

12doi.org

2^nd place

4^th place

doi.org

dx.doi.org

Yamashita M, Ukai-Tadenuma M, Miyamoto T, Sugaya K, Hosokawa H, Hasegawa A, Kimura M, Taniguchi M, DeGregori J, Nakayama T (junho de 2004). «Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci». J Biol Chem. 279 (26): 26983–90. PMID 15087456. doi:10.1074/jbc.M403688200
Kouros-Mehr Hosein, Slorach EM, Sternlicht MD, Werb Z (dezembro de 2006). «GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland». Cell. 127 (5): 1041–55. PMC 2646406. PMID 17129787. doi:10.1016/j.cell.2006.09.048
Wilson BJ (2008). «Does GATA3 act in tissue-specific pathways? A meta-analysis-based approach». J. Carcinogenesis. 7. 6 páginas. PMC 2669725. PMID 19008565. doi:10.4103/1477-3163.43426
Koboldt DC, Fulton RS, McLellan MD; et al. (setembro de 2012). «Comprehensive molecular portraits of human breast tumours». Nature. 490 (7418). PMC 3465532. PMID 23000897. doi:10.1038/nature11412
Wilson BJ, Giguere V (2008). «Meta-analysis of human cancer microarrays reveals that GATA3 is integral to the estrogen receptor alpha pathway». Mol Cancer. 7. 49 páginas. PMC 2430971. PMID 18533032. doi:10.1186/1476-4598-7-49
Dydensborg AB, Rose AA, Wilson BJ, Grote D, Paquet M, Giguère V, Siegel PM, Bouchard M. (julho de 2009). «GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis». Oncogene. 28 (29): 2634–42. PMID 19483726. doi:10.1038/onc.2009
Kouros-Mehr Hosein, Kim JW, Bechis SK, Werb Z (abril de 2008). «GATA-3 and the regulation of the mammary luminal cell fate». Curr. Opin. Cell Biol. 20 (2): 164–70. PMC 2397451. PMID 18358709. doi:10.1016/j.ceb.2008.02.003
Jacquemier J, Charafe-Jauffret E, Monville F, Esterni B, Extra JM, Houvenaeghel G, Xerri L, Bertucci F, Birnbaum D (2009). «Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer». Breast Cancer Res. 11 (2): R23. PMC 2688952. PMID 19405945. doi:10.1186/bcr2249
Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N, Schmitt F (2009). «Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours». Breast Cancer Res. 11 (3): R40. PMC 2716509. PMID 19549328. doi:10.1186/bcr2327
Kouros-Mehr Hosein, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z (fevereiro de 2008). «GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model». Cancer Cell. 13 (2): 141–52. PMC 2262951. PMID 18242514. doi:10.1016/j.ccr.2008.01.011
McCune K, Bhat-Nakshatri P, Thorat MA, Nephew KP, Badve S, Nakshatri H (janeiro de 2010). «Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet». Cancer Res. 70 (2): 685–96. PMC 2807987. PMID 20068169. doi:10.1158/0008-5472.CAN-09-1530
Ono Y, Fukuhara N, Yoshie O (fevereiro de 1997). «Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL». J. Biol. Chem. 272 (7): 4576–81. PMID 9020185. doi:10.1074/jbc.272.7.4576

nih.gov

ncbi.nlm.nih.gov

Joulin V, Bories D, Eleouet JF, Labastie MC, Chretien S, Mattei MG, Romeo PH (julho de 1991). «A T-cell specific TCR delta DNA binding protein is a member of the human GATA family». EMBO J. 10 (7): 1809–16. PMC 452855. PMID 2050118
Yamashita M, Ukai-Tadenuma M, Miyamoto T, Sugaya K, Hosokawa H, Hasegawa A, Kimura M, Taniguchi M, DeGregori J, Nakayama T (junho de 2004). «Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci». J Biol Chem. 279 (26): 26983–90. PMID 15087456. doi:10.1074/jbc.M403688200
«Entrez Gene: GATA3 GATA binding protein 3»
Kouros-Mehr Hosein, Slorach EM, Sternlicht MD, Werb Z (dezembro de 2006). «GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland». Cell. 127 (5): 1041–55. PMC 2646406. PMID 17129787. doi:10.1016/j.cell.2006.09.048
Wilson BJ (2008). «Does GATA3 act in tissue-specific pathways? A meta-analysis-based approach». J. Carcinogenesis. 7. 6 páginas. PMC 2669725. PMID 19008565. doi:10.4103/1477-3163.43426
Koboldt DC, Fulton RS, McLellan MD; et al. (setembro de 2012). «Comprehensive molecular portraits of human breast tumours». Nature. 490 (7418). PMC 3465532. PMID 23000897. doi:10.1038/nature11412
Wilson BJ, Giguere V (2008). «Meta-analysis of human cancer microarrays reveals that GATA3 is integral to the estrogen receptor alpha pathway». Mol Cancer. 7. 49 páginas. PMC 2430971. PMID 18533032. doi:10.1186/1476-4598-7-49
Dydensborg AB, Rose AA, Wilson BJ, Grote D, Paquet M, Giguère V, Siegel PM, Bouchard M. (julho de 2009). «GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis». Oncogene. 28 (29): 2634–42. PMID 19483726. doi:10.1038/onc.2009
PMID 19747394 (PubMed)
Kouros-Mehr Hosein, Kim JW, Bechis SK, Werb Z (abril de 2008). «GATA-3 and the regulation of the mammary luminal cell fate». Curr. Opin. Cell Biol. 20 (2): 164–70. PMC 2397451. PMID 18358709. doi:10.1016/j.ceb.2008.02.003
Jacquemier J, Charafe-Jauffret E, Monville F, Esterni B, Extra JM, Houvenaeghel G, Xerri L, Bertucci F, Birnbaum D (2009). «Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer». Breast Cancer Res. 11 (2): R23. PMC 2688952. PMID 19405945. doi:10.1186/bcr2249
Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N, Schmitt F (2009). «Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours». Breast Cancer Res. 11 (3): R40. PMC 2716509. PMID 19549328. doi:10.1186/bcr2327
Kouros-Mehr Hosein, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z (fevereiro de 2008). «GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model». Cancer Cell. 13 (2): 141–52. PMC 2262951. PMID 18242514. doi:10.1016/j.ccr.2008.01.011
McCune K, Bhat-Nakshatri P, Thorat MA, Nephew KP, Badve S, Nakshatri H (janeiro de 2010). «Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet». Cancer Res. 70 (2): 685–96. PMC 2807987. PMID 20068169. doi:10.1158/0008-5472.CAN-09-1530
Ono Y, Fukuhara N, Yoshie O (dezembro de 1998). «TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3». Mol. Cell. Biol. 18 (12): 6939–50. PMC 109277. PMID 9819382
Ono Y, Fukuhara N, Yoshie O (fevereiro de 1997). «Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL». J. Biol. Chem. 272 (7): 4576–81. PMID 9020185. doi:10.1074/jbc.272.7.4576